Sub-acute Exercise Following Sport-Related Concussion
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03575455 |
|
Recruitment Status :
Completed
First Posted : July 2, 2018
Last Update Posted : September 16, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Sport-related Concussion | Behavioral: Exercise | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 30 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Randomized block design using age and sex to randomize into 3 injured groups (40%, 60%, CON) and matching for 3 healthy groups (40%, 60%, CON) |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | The Short- And Long-Term Effects Of Submaximal Aerobic Exercise On Recovery Following Sport-Related Concussion In High School Student-Athletes |
| Actual Study Start Date : | January 2, 2017 |
| Actual Primary Completion Date : | March 1, 2019 |
| Actual Study Completion Date : | July 1, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Exercise
Concussed participants will participate in a single 20' bout of treadmill walking at either 40% or 60% of the age-predicted HRmax. Healthy participants will participate in a single 20' bout of treadmill walking at either 40% or 60% of the age-predicted HRmax. |
Behavioral: Exercise
HR-controlled treadmill walking
Other Name: Aerobic exercise |
|
No Intervention: Seated Control
Concussed participants will participate in a single 20' treatment session of seated rest. Healthy participants will participate in a single 20' treatment session of seated rest. |
- Clinical Recovery [ Time Frame: The number of days from injury to full medical clearance up to 365 days. 80% of adolescent athletes fully recover in less than 28 days. ]Clinical recovery is defined as the duration from the time of injury to the time a patient has received full clearance without restriction.
- Heart rate variability (HRV) [ Time Frame: HRV will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment". ]The RR Interval will be extracted from the heart rate monitoring system.
- Blood Pressure (SBP & DBP) [ Time Frame: SBP & DBP will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment". ]SBP & DBP will be recorded with an automated auscultatory BP system
- Ocular Dysfunction [ Time Frame: The King-Devick (K-D) will be administered before and within 5 minutes after the acute 20 minute "treatment" ]Improvements in ocular dysfunction will be defined as a decrease in errors or reading time
- Vestibular Dysfunction [ Time Frame: The Vestibular / Ocular Motor Screening (VOMS) will be administered before and within 5 minutes after the acute 20 minute "treatment" ]Improvements in vestibular dysfunction will be defined as a decrease in symptom provocation or pretest symptom reporting
- Rating of Perceived Exertion (RPE) [ Time Frame: RPE will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment". ]Borg's CR-15 will be utilized to quantifying perceived intensity of exercise
- Concussion Symptoms [ Time Frame: Symptoms will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment". ]All 22 symptoms from the Post-concussion symptom scale (PCSS) as measured on a Likert scale from 0 (not present) to 6 (severe)
- Exercise Bout Completion Rates [ Time Frame: Completion will be determined and recorded at the end of the acute 20 minute treatment. ]The rate of completion will be defined as the ability for the participant to finish the "treatment" without early termination.
- Incidence of Persistent Postconcussion symptoms >28 days [ Time Frame: The duration in days will be calculated from the day injury to the day full clearance up to 1 year. ]Persistent symptoms duration will be categorized as either ≤28 days or > 28 days.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 13 Years to 18 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria (concussed):
- high school student-athlete
- suffered a diagnosed concussion
- evaluated between Day 3 and Day 7 since injury
Inclusion Criteria (healthy):
- high school student-athlete
- no diagnosed concussion within the last year
- matched with concussion participant for age and gender
Exclusion Criteria:
- physical limitation prohibiting treadmill walking
- reports dizziness or lightheadedness
- presents with any contraindication for exercise participation as defined by American College of Cardiology (ACC), American Heart Association (AHA), or American College of Sports Medicine (ACSM) guidelines.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03575455
| United States, Florida | |
| Tallahassee Orthopedic Clinic | |
| Tallahassee, Florida, United States, 32308 | |
| Responsible Party: | Phillip Worts, Principle Investigator, Florida State University |
| ClinicalTrials.gov Identifier: | NCT03575455 |
| Other Study ID Numbers: |
RF02521 - TOC |
| First Posted: | July 2, 2018 Key Record Dates |
| Last Update Posted: | September 16, 2020 |
| Last Verified: | September 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
concussion aerobic exercise sub-acute |

